Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Glanzmann Thrombasthenia – A Rare but Important Platelet Disorder – Iranian Comprehensive Hemophilia Care Center
ICHCC/LinkedIn
Jun 8, 2026, 12:02

Glanzmann Thrombasthenia – A Rare but Important Platelet Disorder – Iranian Comprehensive Hemophilia Care Center

Iranian Comprehensive Hemophilia Care Center  (ICHCC)  shared a post on LinkedIn:

“Glanzmann Thrombasthenia: A Rare but Important Platelet Disorder

Glanzmann Thrombasthenia (GT) is a rare inherited platelet function disorder caused by deficiency or dysfunction of the platelet glycoprotein IIb/IIIa (αIIbβ3 integrin), resulting in impaired platelet aggregation.

Key Clinical Features:

  • Recurrent epistaxis
  • Easy bruising
  • Gingival bleeding
  • Menorrhagia
  • Excessive bleeding after surgery or dental procedures

Laboratory Findings:

  • Normal platelet count and morphology
  • Normal PT and aPTT
  • Prolonged bleeding time or abnormal PFA
  • Absent platelet aggregation with ADP, collagen, arachidonic acid, and epinephrine
  • Normal agglutination with ristocetin

Diagnosis:

  • Platelet aggregation studies
  • Flow cytometry for CD41/CD61 expression
  • Molecular testing of ITGA2B and ITGB3 genes

Management:

  • Local hemostatic measures
  • Antifibrinolytic agents (tranexamic acid)
  • Platelet transfusion for major bleeding
  • Recombinant factor VIIa in refractory cases or platelet alloimmunization
  • Genetic counseling

Diagnostic Pearl:
‘Normal ristocetin response with absent aggregation to all other agonists’ is the classic laboratory signature of Glanzmann Thrombasthenia.”

Iranian Comprehensive Hemophilia Care Center

Stay updated with Hemostasis Today.

Glanzmann thrombasthenia Glanzmann Thrombasthenia (GT) Health Hematology Hemostasis Hemostasis News Hemostasis Today Iranian Comprehensive Hemophilia Care Center Medicine
NewsFeed